Page last updated: 2024-08-16

rivastigmine and Developmental Psychomotor Disorders

rivastigmine has been researched along with Developmental Psychomotor Disorders in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ballard, C; Emre, M; He, Y; Lane, R; Leverenz, JB; Morris, C	1
Cruz-Jentoft, AJ; del Ser, T; Fernández-Bullido, Y; Frank, A; Galiano, M; García de la Rocha, ML; González-Salvador, MT; Muñiz, R; Navarro, E; Olazarán, J; Peña-Casanova, J; Reisberg, B; Serra, JA; Serrano, P; Sevilla, C	1
Aarsland, D; Brønnick, K; De Deyn, PP; Ehrt, U; Emre, M; Lane, R; Tekin, S	1

Trials

2 trial(s) available for rivastigmine and Developmental Psychomotor Disorders

Article	Year
Benefits of cognitive-motor intervention in MCI and mild to moderate Alzheimer disease. Neurology, 2004, Dec-28, Volume: 63, Issue:12 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Caregivers; Cholinesterase Inhibitors; Cognition Disorders; Cognitive Behavioral Therapy; Combined Modality Therapy; Donepezil; Female; Follow-Up Studies; Humans; Indans; Male; Middle Aged; Patient Satisfaction; Patients; Phenylcarbamates; Physical Therapy Modalities; Piperidines; Psychomotor Disorders; Rivastigmine; Single-Blind Method; Treatment Outcome	2004
Subthreshold depression in patients with Parkinson's disease and dementia--clinical and demographic correlates. International journal of geriatric psychiatry, 2007, Volume: 22, Issue:10 Topics: Age Factors; Age of Onset; Aged; Aged, 80 and over; Cholinesterase Inhibitors; Dementia; Depressive Disorder; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Phenylcarbamates; Psychomotor Disorders; Rivastigmine; Sex Factors	2007

Article

Year

Benefits of cognitive-motor intervention in MCI and mild to moderate Alzheimer disease.

Neurology, 2004, Dec-28, Volume: 63, Issue:12

Topics: Aged; Aged, 80 and over; Alzheimer Disease; Caregivers; Cholinesterase Inhibitors; Cognition Disorders; Cognitive Behavioral Therapy; Combined Modality Therapy; Donepezil; Female; Follow-Up Studies; Humans; Indans; Male; Middle Aged; Patient Satisfaction; Patients; Phenylcarbamates; Physical Therapy Modalities; Piperidines; Psychomotor Disorders; Rivastigmine; Single-Blind Method; Treatment Outcome

2004

Subthreshold depression in patients with Parkinson's disease and dementia--clinical and demographic correlates.

International journal of geriatric psychiatry, 2007, Volume: 22, Issue:10

Topics: Age Factors; Age of Onset; Aged; Aged, 80 and over; Cholinesterase Inhibitors; Dementia; Depressive Disorder; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Phenylcarbamates; Psychomotor Disorders; Rivastigmine; Sex Factors

2007

Other Studies

1 other study(ies) available for rivastigmine and Developmental Psychomotor Disorders

Article	Year
BuChE-K and APOE epsilon4 allele frequencies in Lewy body dementias, and influence of genotype and hyperhomocysteinemia on cognitive decline. Movement disorders : official journal of the Movement Disorder Society, 2009, Feb-15, Volume: 24, Issue:3 Topics: Aged; Apolipoprotein E4; Butyrylcholinesterase; Cognition Disorders; Female; Gene Frequency; Genotype; Humans; Hyperhomocysteinemia; Lewy Body Disease; Male; Neuroprotective Agents; Neuropsychological Tests; Phenylcarbamates; Psychomotor Disorders; Randomized Controlled Trials as Topic; Rivastigmine; Severity of Illness Index	2009

Article

Year

BuChE-K and APOE epsilon4 allele frequencies in Lewy body dementias, and influence of genotype and hyperhomocysteinemia on cognitive decline.

Movement disorders : official journal of the Movement Disorder Society, 2009, Feb-15, Volume: 24, Issue:3

Topics: Aged; Apolipoprotein E4; Butyrylcholinesterase; Cognition Disorders; Female; Gene Frequency; Genotype; Humans; Hyperhomocysteinemia; Lewy Body Disease; Male; Neuroprotective Agents; Neuropsychological Tests; Phenylcarbamates; Psychomotor Disorders; Randomized Controlled Trials as Topic; Rivastigmine; Severity of Illness Index

2009